Abbott Laboratories (NYSE:ABT) over-valued by 8%
Website | https://www.abbott.com |
Sector | Healthcare |
Industry | Medical Devices |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $206,786,297,856 |
Beta | 0.677005 |
Average Volume | $5,018,203 |
Last Dividend | 1.62% |
Price on Aug 2, 2022 | $110.49 |
Autochartist™ Valuation | $101.71 |
Conclusion |
8% over-valued |
Download Report |